Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 29 results for "lupin ltd"

Lupin hits near 3-year low, technicals suggest further downside

Lupin hits near 3-year low, technicals suggest further downside

Shares of Lupin Ltd fall as much as 2.3 pct to 1,070.1 rupees, their lowest since July 2014. Stock breaks a support at 1,101.4 rupees, the 76.4 pct projection level of wave A. Stock rides wave C of a three-wave corrective pattern, wave C might take the stock ... Sify, 3 days ago

8 images for lupin ltd

Sify, 3 days ago
Money Control, 5 days ago
Sify, 1 month ago
Money Today, 3 months ago
Money Control, 3 months ago
State Times , 3 months ago
Money Control, 3 months ago, 7 months ago

Global Share Markets End the Week on a Dull Note

Posted by Equitymaster Global financial markets ended the week on a dull note. This was on back of the Federal Reserve's release of its May 2-3 policy meeting minutes. After raising the benchmark interest rate by 25 basis points. The Fed seemed to be open to ...
 Equitymaster.com1 day ago Brazil Leads Global Market Rally on Hopes of Political Reform  Equitymaster.com4 weeks ago Global Markets End the Week Higher Tracking French Polls; US Fed Keeps Rates Unchanged  Equitymaster.com1 month ago US Strikes on Syria Keep a Lid on Global Financial Markets  Equitymaster.com2 months ago

Indian Indices Trade in Red; Metal Stocks Drag

Posted by Equitymaster After opening the day marginally lower, share markets in India have continued the downtrend and are currently trading below the dotted line. Sectoral indices are trading on a mixed note with stocks in the realty sector and stocks in the ...
 Equitymaster.com4 days ago Indian Indices Trade in Red; Pharma Stocks Witness Buying  Equitymaster.com1 week ago Dull Start to the Week; Pharma & Metal Stocks Fall  Equitymaster.com1 month ago

Drugmaker Lupin's profit halves as U.S. sales slump

MUMBAI (Reuters) - Indian drugmaker Lupin Ltd reported its quarterly net profit nearly halved from a year ago, falling far short of analysts' expectations, as sales at its top market the United States slumped while the company's costs jumped.
 Business Standard1 month ago Lupin Q4 net profit halves  Sify1 month ago
Money Control

Lupin launches erectile dysfunction drug Cialis

Domestic pharma major Lupin Ltd today launched erectile dysfunction treatment medicine Cialis in India through an exclusive licensing pact with Eli Lilly. Lupin has acquired the rights to market, promote and distribute Lilly's erectile dysfunction (ED) ...
 Business Standard1 month ago
Med India

Generic HIV Drugs Launched by Lupin In The US

Lupin Ltd, a pharmaceutical company launched generic Abacavir and Lamivudine tablets for HIV in the US. In a regulatory filing in BSE, the company said it has launched Abacavir and Lamivudine tablets 600 mg/300 mg after an approval from the United States Food ...
 Med India2 months ago Lupin gets USFDA nod for generic hypertension drug  Business Standard1 month ago Lupin launches HIV tablets in the US  Prokerala2 months ago Lupin launches generic HIV drug in US market  Business Standard2 months ago

Lupin warns of more pricing pressure as fourth-quarter profit halves

Indian drugmaker Lupin Ltd expects to launch over 30 products in the United States this year, but warned revenue growth would remain muted due to growing pricing pressure and competition in the world's largest healthcare market. "We've talked about medium ...
 Reuters1 month ago

Lupin slumps to near 3-year low on weak quarterly results

Lupin Ltd falls as much as 7.7 pct to its lowest since Aug. 8, 2014. Pharma company posted a 49 pct fall in consolidated net profit for the March quarter, missing analysts' estimates. Says it expects more pricing pressure in the United States and is currently ...
 Sify1 month ago BUZZ-India's Lupin slumps to near 3-yr low on weak qtrly results  Sify1 month ago

Lupin extends losses, loses m-cap by Rs 3,315 cr in 2 days

Registering losses for the second day, Lupin today fell by 3 per cent on US health regulator's observations for its Goa plant. The stock of the company declined by 3.09 per cent to end at Rs 1,264.20 on the BSE. During the day, it slipped 3.3 per cent to Rs ...
 Business Standard1 month ago
Money Today

Sun Pharma says 2018 sales may fall as US market gets tougher

Reuters New Delhi Last Updated: May 27, 2017 | 10:30 IST India's largest drug group Sun Pharmaceutical Industries Ltd said on Friday its U.S. sales might fall this year because of pressure on drug prices, signalling tough market conditions in the United ...
 Money Today4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less